Form 15-12G - Securities registration termination [Section 12(g)]:
SEC Accession No. 0001104659-23-108337
Filing Date
2023-10-10
Accepted
2023-10-10 16:56:54
Documents
1
Effectiveness Date
2023-10-10

Document Format Files

Seq Description Document Type Size
1 15-12G tm2327727d1_1512g.htm 15-12G 8168
  Complete submission text file 0001104659-23-108337.txt   9185
Mailing Address 1325 BOYLSTON STREET SUITE 500 BOSTON MA 02215
Business Address 1325 BOYLSTON STREET SUITE 500 BOSTON MA 02215 617-370-8701
Decibel Therapeutics, Inc. (Filer) CIK: 0001656536 (see all company filings)

EIN.: 464198709 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 15-12G | Act: 34 | File No.: 001-40030 | Film No.: 231318533
SIC: 2834 Pharmaceutical Preparations